References
- Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154: 357–65
- Berger F, Goulet V, Le Strat Y, de Valk H, Désenclos J. Toxoplasmosis in pregnant women in 2003, seroprevalence and associated factors. Institut de Veille Sanitaire, Paris 2007
- Abgrall S, Rabaud C, Costagliola D. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis 2001; 33: 1747–55
- Katlama C, De Wit S, O'Doherty E, Van Glabeke M, Clumeck N. Pyrimethamine–clindamycin vs. pyrimethamine–sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1996; 22: 268–75
- National Institutes of Health; the Centers for Disease Control and Prevention; the HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. June 18, 2008. Available at: http://aidsinfo.nih.gov/contentfiles/Adult_OI.pdf, , accessed July 2009.
- Araujo FG, Prokocimer P, Remington JS. Clarithromycin–minocycline is synergistic in a murine model of toxoplasmosis. J Infect Dis 1992; 165: 788
- Derouin F, Caroff B, Chau F, Prokocimer P, Pocidalo JJ. Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. Antimicrob Agents Chemother 1992; 36: 2852–5
- Lacassin F, Schaffo D, Perronne C, Longuet P, Leport C, Vilde JL. Clarithromycin–minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1995; 39: 276–7
- Grenier D, Huot MP, Mayrand D. Iron-chelating activity of tetracyclines and its impact on the susceptibility of Actinobacillus actinomycetemcomitans to these antibiotics. Antimicrob Agents Chemother 2000; 44: 763–6
- Pradines B, Rogier C, Fusai T, Mosnier J, Daries W, Barret E, et al. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Antimicrob Agents Chemother 2001; 45: 1746–50
- Furco A, Carmagnat M, Chevret S, Garin YJ, Pavie J, De Castro N, et al. Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART. AIDS 2008; 22: 2087–96
- Hoffmann C, Ernst M, Meyer P, Wolf E, Rosenkranz T, Plettenberg A, et al. Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responses. Clin Microbiol Infect 2007; 13: 510–5